BioXcel Therapeutics Competitors and Similar CompaniesClear all
Merus's competitors and similar companies include Cue Biopharma.
 Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Cue Biopharma Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. | |
Founding Date | Founding Date 2003 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations Cambridge, US HQ |
Employees | Employees 260 | Employees 4664% increase |
Valuation ($) | Valuation ($) 3.6 b | Valuation ($) 107.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) $27.5m (FY, 2025) |
Net income | Net income ($215.3m) (FY, 2024) | Net income ($26.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Cue Biopharma
HQ
Cambridge, US
Employees
46
Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease.
View company